JC Virus Reactivation in Multiple Sclerosis

Trial Profile

JC Virus Reactivation in Multiple Sclerosis

Phase of Trial: Phase IV

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Natalizumab (Primary) ; Interferon beta
  • Indications Multiple sclerosis; Progressive multifocal leukoencephalopathy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top